AUPH vs BXP · P/E 28, rev $283.1M vs rev $3.48B
Aurinia Pharmaceuticals Inc (AUPH) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. BXP currently screens at market cap $12.12B.
Not investment advice. Open the AUPH and BXP stock pages for the full models.
Not investment advice.